Business Context and Reporting Period
Company: BioRestorative Therapies, Inc. (BRTX)
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2024
Reporting Period: Event-based disclosure regarding an upcoming investor conference.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely as a disclosure of a corporate event.
Material Changes
No material changes to financial position or operations are reported in this filing. The primary event is the announcement of management participation in an external conference.
Guidance, Outlook, and Management Commentary
- Event: The Company will participate in the 36th Annual ROTH Conference held March 17–19, 2024, at the Ritz Carlton in Dana Point, California.
- Management Participation: Lance Alstodt, President and CEO, is scheduled to participate in a fireside chat.
- Materials: Presentation materials (Exhibit 99.2) and a press release (Exhibit 99.1) are furnished with this report.
- Legal Status: Information furnished under Item 7.01 (Regulation FD) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the Press Release (Exhibit 99.1) and Presentation Materials (Exhibit 99.2) attached to the filing for specific business updates.
- Confirm the schedule and access details for the 36th Annual ROTH Conference fireside chat.
- Note that this 8-K contains no audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.